Nektar Therapeutics (NKTR) Financials

NKTR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 398.0 million 267.0 million
2023-09-30 442.2 million 282.9 million
2023-06-30 494.3 million 297.3 million
2023-03-31 561.7 million 320.9 million

NKTR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -47.3 million 7.3 million
2023-09-30 -42.2 million 8.1 million
2023-06-30 -51.7 million 8.0 million
2023-03-31 -52.3 million 10.0 million

NKTR Net Income

No data available :(

NKTR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 303.6 million - 117.8 million
2023-09-30 372.7 million - 121.3 million
2023-06-30 409.4 million - 124.8 million
2023-03-31 456.8 million - 128.2 million

NKTR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 191.0 million
2023-09-30 190.4 million
2023-06-30 189.7 million
2023-03-31 188.9 million

NKTR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 237000 29.9 million 17.3 million -
2023-09-30 33000 24.1 million 21.1 million -
2023-06-30 162000 29.7 million 17.9 million -
2023-03-31 433000 30.5 million 21.1 million -

NKTR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 23.9 million 7.3 million
2023-09-30 24.1 million 12.4 million
2023-06-30 20.5 million 7.0 million
2023-03-31 21.6 million 7.1 million

NKTR

Price: $1.50

52 week price:
0.41
1.67

Earnings Per Share: -1.45 USD

P/E Ratio: -0.38

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.8 million

Ebitda: 74.9 million

Market Capitalization: 242.4 million

Links: